Evansville, IN, United States of America

Harry L Hunter

This inventor holds 2 USPTO granted patents. Top assignee: Bristol-Myers Company. Active years: 1987-1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Harry L Hunter. Retrieved from https://idiyas.com/inventor/harry-l-hunter

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1987-1989

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Harry L Hunter

Introduction

Harry L Hunter is a notable inventor based in Evansville, IN (US). He has made significant contributions to the field of medicine, particularly in the treatment of male impotence. With a total of 2 patents to his name, Hunter's work has had a meaningful impact on healthcare.

Latest Patents

Hunter's latest patents focus on a method for the treatment of male impotence. His innovative approach utilizes Trazodone and its pharmaceutically acceptable salts, demonstrating their usefulness in addressing male sexual impotence. This advancement highlights his commitment to improving the quality of life for many individuals.

Career Highlights

Throughout his career, Hunter has been associated with Bristol-Myers Company, where he has been able to apply his expertise in developing effective treatments. His work has not only contributed to the company's portfolio but has also advanced medical science in significant ways.

Collaborations

Hunter has collaborated with esteemed colleagues such as Donald E Gamble and Gordon R McKinney. These partnerships have fostered an environment of innovation and creativity, leading to the development of impactful medical solutions.

Conclusion

In summary, Harry L Hunter is a distinguished inventor whose work in the treatment of male impotence has made a lasting impact. His patents and collaborations reflect his dedication to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…